Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
Alzheimer's disease (AD) is a large and increasing unmet medical need with no disease-modifying treatment currently available. Genetic evidence from genome-wide association studies (GWASs) and gene network analysis has clearly revealed a key role of the innate immune system in the brain, of whi...
Saved in:
Main Authors: | Knut Biber (Author), Anindya Bhattacharya (Author), Brian M. Campbell (Author), Justin R. Piro (Author), Michael Rohe (Author), Roland G.W. Staal (Author), Robert V. Talanian (Author), Thomas Möller (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges
by: Zhenwei Zhang, et al.
Published: (2024) -
Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development
by: Chiranjib Chakraborty, et al.
Published: (2023) -
How drug repurposing can advance drug discovery: challenges and opportunities
by: Luca Pinzi, et al.
Published: (2024) -
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies
by: Alexandre Blanco-González, et al.
Published: (2023) -
New therapeutic modalities in drug discovery and development: Insights & opportunities
by: Manfred Kansy, et al.
Published: (2021)